Clinical Trials
4 trialsNCT00053001 2013-06-26
Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 2 Completed
NCT00030550 2013-01-31
Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome
Roswell Park Cancer Institute
Phase 2 Completed
NCT00015990 2013-01-24
Thalidomide in Treating Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 2 Completed
NCT00053287 2010-06-10
Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS
Case Comprehensive Cancer Center
Phase 2 Completed